BlackRock »

Nuvectis Pharma shares owned by BlackRock

Quarter-by-quarter ownership of Nuvectis Pharma (NVCT) shares owned by BlackRock from 13F filings

Historical chart of BlackRock investment in Nuvectis Pharma

Tip: Access up to 7 years of quarterly data

All positions including Nuvectis Pharma held by BlackRock consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Nuvectis Pharma by BlackRock

Quarter filed Position value Share count Share price at filing
2024-09-30 $312k 50k 6.29

More positions owned by BlackRock

Apple (AAPL)
Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Alphabet Cap Stk Cl C (GOOG)
Eli Lilly & Co. (LLY)
Tesla Motors (TSLA)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
UnitedHealth (UNH)
JPMorgan Chase & Co. (JPM)
Ishares Tr Core S&p500 Etf (IVV)
Visa Com Cl A (V)

View all positions for BlackRock

Top funds holding Nuvectis Pharma

Vanguard Group
Baldwin Brothers
BlackRock
Geode Capital Management
Goldman Sachs Group
Iridian Asset Management
GSA Capital Partners
BlackRock
Paul Kendrigan
Marshall Wace
Susquehanna International
Renaissance Technologies
State Street Corporation
Northern Trust
Two Sigma Investments

View all funds holding Nuvectis Pharma